Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-γ activation after stress in rats

Endocrinology

Volumn 149, Issue 4, 2008, Pages 1969-1978

  García Bueno, Borja ^a   Madrigal, José L M ^a   Pérez Nievas, Beatriz G ^a   Leza, Juan Carlos ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Instituto Nacional de Toxicologia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATECHOLAMINE DERIVATIVE; CYCLOOXYGENASE 2; EXCITATORY AMINO ACID; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUTAMIC ACID; MINERALOCORTICOID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN J2;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN; CONTROLLED STUDY; IMMOBILIZATION STRESS; INFLAMMATION; MALE; MEDIATOR; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; REGULATORY MECHANISM;

ANIMALS; BRAIN; CATECHOLAMINES; CORTICOSTERONE; DINOPROSTONE; GLUCOCORTICOIDS; GLUTAMIC ACID; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MALE; PPAR GAMMA; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL;

EID: 41549112494     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0482     Document Type: Article

References (82)

1. Selye H 1936 A syndrome produced by diverse nocuous agents. Nature 138:32
2. Moghaddam B 1993 Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 60:1650-1657
3. Black PH 2002 Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 16:622-653
4. Baum A, Posluszny DM 1999 Health psychology: mapping biobehavioral contributions to health and illness. Annu Rev Psychol 50:137-163
5. Slimmer LM, Lyness JM, Caine ED 2001 Stress, medical illness, and depression. Semin Clin Neuropsychiatry 6:12-26
6. Lucas SM, Rothwell NJ, Gibson RM 2006 The role of inflammation in CNS injury and disease. Br J Pharmacol 147(Suppl 1):S232-S240
7. Mattson MP, Culmsee C, Yu Z, Camandola S 2000 Roles of nuclear factor κB in neuronal survival and plasticity. J Neurochem 74:443-456
8. Culman J, Zhao Y, Gohlke P, Herdegen T 2007 PPAR-γ: therapeutic target for ischemic stroke. Trends Pharmacol Sci 28:244-249
9. McLeod TM, Lopez-Figueroa AL, Lopez-Figueroa MO 2001 Nitric oxide, stress, and depression. Psychopharmacol Bull 35:24-41
10. Madrigal JL, Garcia-Bueno B, Caso JR, Perez-Nievas BG, Leza JC 2006 Stress-induced oxidative changes in brain. CNS Neurol Disord Drug Targets 5:561-568
11. Oka T, Oka K, Hori T 2001 Mechanisms and mediators of psychological stress-induced rise in core temperature. Psychosom Med 63:476-486
12. Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Fernandez AP, Rodrigo J, Bosca L, Leza JC 2000 Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem 74:785-791
13. Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Fernández AP, Rodrigo J, Boscá L, Leza JC 2003 Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 28:1579-1588
14. Madrigal JL, Garcia-Bueno B, Moro MA, Lizasoain I, Lorenzo P, Leza JC 2003 Relationship between cyclooxygenase-2 and nitric oxide synthase-2 in rat cortex after stress. Eur J Neurosci 18:1701-1705
15. Miller SB 2006 Prostaglandins in health and disease: an overview. Semin Arthritis Rheum 36:37-49
16. Minghetti L 2004 Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63:901-910
17. O'Banion MK 1999 Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 13:45-82
18. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL 2002 COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99:13926-13931
19. Hoffmann C 2000 COX-2 in brain and spinal cord implications for therapeutic use. Curr Med Chem 7:1113-1120
20. Murakami M, Nakatani Y, Tanioka T, Kudo I 2002 Prostaglandin E synthase. Prostaglandins Other Lipid Mediat 68-69:383-399
21. Urade Y, Hayaishi O 2000 Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta 1482:259-271
22. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF 1993 Expression of a mitogen-inducible cyclooxygenase in brain neurones: regulation by synaptic activity and glucocorticoids. Neuron 11:371-386
23. Bugajski AJ, Gadek-Michalska A, Bugajski J 2006 The involvement of nitric oxide and prostaglandins in the cholinergic stimulation of hypothalamic-pituitary-adrenal response during crowding stress. J Physiol Pharmacol 57:463-477
24. Dhir A, Padi SS, Naidu PS, Kulkarni SK 2006 Protective effect of naproxen (nonselective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice. Eur J Pharmacol 535:192-198
25. Tanaka A, Hatazawa R, Takahira Y, Izumi N, Filaretova L, Takeuchi K 2007 Preconditioning stress prevents cold restraint stress-induced gastric lesions in rats: roles of COX-1, COX-2, and PLA2. Dig Dis Sci 52:478-487
26. 2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. Psychopharmacology (Berl) 180:513-522
27. Garcia-Bueno B, Madrigal JL, Lizasoain I, Moro MA, Lorenzo P, Leza JC 2005 Peroxisome proliferator-activated receptor γ activation decreases neuroinflammation in brain after stress in rats. Biol Psychiatry 57:885-894
28. Castrillo A, Tontonoz P 2004 Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu Rev Cell Dev Biol 20:455-480
29. Moreno S, Farioli-Vecchioli S, Ceru MP 2004 Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123:131-145
30. Heneka MT, Klockgether T, Feinstein DL 2000 Peroxisome proliferator-activated receptor-γ ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J Neurosci [Erratum (2000) 20:1a] 20:6862-6867
31. Feinstein DL 2003 Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease. Diabetes Technol Ther 5:67-73
32. Kim EH, Surh YJ 2006 15-Deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem Pharmacol 72:1516-1528
33. Sundararajan S, Jiang Q, Heneka M, Landreth G 2006 PPARγ as a therapeutic target in central nervous system diseases. Neurochem Int 49:136-144
34. Garcia-Bueno B, Caso JR, Perez-Nievas BG, Lorenzo P, Leza JC 2007 Effects of peroxisome proliferator-activated receptor γ agonists on brain glucose and glutamate transporters after stress in rats. Neuropsychopharmacology 32:1251-1260
35. Leza JC, Salas E, Sawicki G, Russell JC, Radomski MW 1998 The effect of stress on homeostasis in JCR:LA-cp rats: the role of nitric oxide. J Pharmacol Exp Ther 286:1397-1403
36. Glavin GB, Pare WP, Sandbak T, Bakke HK, Murison R 1994 Restraint stress in biomedical research: an update. Neurosci Biobehav Rev 18:223-249
37. Schreiber E, Matthias P, Müller MM, Schaffner W 1989 Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res 17:6419
38. Rotllant D, Ons S, Carrasco J, Armario A 2002 Evidence that metyrapone can act as a stressor: effect on pituitary-adrenal hormones, plasma glucose and brain c-fos induction. Eur J Neurosci 16:693-700
39. Rotllant D, Armario A 2005 A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat. Neuroscience 130:427-434
40. Nadeau S, Rivest SJ 2002 Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14. Immunology 169:3370-3381
41. Yang Y, Zheng X, Wang Y, Cao J, Dong Z, Cai J, Sui N, Xu L 2004 Stress enables synaptic depression in CA1 synapses by acute and chronic morphine: possible mechanisms for corticosterone on opiate addiction. J Neurosci 24:2412-2420
42. Mayer JL, Klumpers L, Maslam S, de Kloet ER, Joels M, Lucassen PJ 2006 Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. J Neuroendocrinol 18:629-631
43. Mattsson C, Lai M, Noble J, McKinney E, Yau JL, Seckl JR, Walker BR 2003 Obese Zucker rats have reduced mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase type 1 expression in hippocampus- implications for dysregulation of the hypothalamic-pituitary-adrenal axis in obesity. Endocrinology 144:2997-3003
44. Avital A, Segal M, Richter-Levin G 2006 Contrasting roles of corticosteroid receptors in hippocampal plasticity. J Neurosci 26:9130-9134
45. Cao L, Hudson CA, Lawrence DA 2003 Immune changes during acute cold/restraint stress-induced inhibition of host resistance to Listeria. Toxicol Sci 74:325-334
46. Roozendaal B, McReynolds JR, McGaugh JL 2004 The basolateral amygdala interacts with the medial prefrontal cortex in regulating glucocorticoid effects on working memory impairment. J Neurosci 24:1385-1392
47. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Greenwood BN, Fleshner M 2005 Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 135:1295-1307
48. Nakade Y, Tsuchida D, Fukuda H, Iwa M, Pappas TN, Takahashi T 2005 Restraint stress delays solid gastric emptying via a central CRF and peripheral sympathetic neuron in rats. Am J Physiol Regul Integr Comp Physiol 288:R427-R432
49. Eijkelkamp N, Engeland CG, Gajendrareddy PK, Marucha PT 2007 Restraint stress impairs early wound healing in mice via α-adrenergic but not β-adrenergic receptors. Brain Behav Immun 21:409-412
50. Wong EH, Knight AR, Woodruff GN 1988 [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J Neurochem 50:274-281
51. Jezova D, Tokarev D, Rusnak M 1995 Endogenous excitatory amino acids are involved in stress-induced adrenocorticotropin and catecholamine release. Neuroendocrinology 62:326-332
52. Hill HD, Straka JG 1988 Protein determination using bicinchoninic acid in the presence of sulfhydryl reagents. Anal Biochem 170:203-208
53. Birkle DL, Wright KF, Ellis CK, Ellis EF 1981 Prostaglandin levels in isolated brain microvessels and in normal and norepinephrine-stimulated cat brain homogenates. Prostaglandins 21:865-877
54. Hillier K, Templeton WW 1982 Stimulation of prostaglandin synthesis in rat cerebral cortex via a β-adrenoceptor. Gen Pharmacol 13:21-25
55. Rettori V, Gimeno M, Lyson K, McCann SM 1992 Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus. Proc Natl Acad Sci USA 89:11543-11546
56. Kabbaj M, Morley-Fletcher S, Le Moal M, Maccari S 2007 Individual differences in the effects of chronic prazosin hydrochloride treatment on hippocampal mineralocorticoid and glucocorticoid receptors. Eur J Neurosci. 25:3312-3318
57. Galea E, Heneka MT, Dello Russo C, Feinstein DL 2003 Intrinsic regulation of brain inflammatory responses. Cell Mol Neurobiol 23:625-635
58. Inoue H, Tanabe T, Umesono K 2000 Feedback control of cyclooxygenase-2 expression through PPARγ. J Biol Chem 275:28028-28032
59. Simonin MA, Bordji K, Boyault S, Bianchi A, Gouze E, Becuwe P, Dauca M, Netter P, Terlain B 2002 PPAR-γ ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Am J Physiol Cell Physiol 282:C125-C133
60. Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY 2005 Contrasting effects of peroxisome-proliferator- activated receptor (PPAR) γ agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1β-stimulated rat chondrocytes: evidence for PPARγ-independent inhibition by 15-deoxy-Δ12, 14prostaglandin J2. Arthritis Res Ther 7:R1325-R1337
61. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M 1998 Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301
62. Cover PO, Slater D, Buckingham JC 2001 Expression of cyclooxygenase enzymes in rat hypothalamo-pituitary-adrenal axis: effects of endotoxin and glucocorticoids. Endocrine 16:123-131
63. Beilin B, Shavit Y, Dekeyser F, Itzik A, Weidenfeld J 2006 The involvement of glucocorticoids and interleukin-1 in the regulation of brain prostaglandin production in response to surgical stress. Neuroimmunomodulation 13:36-42
64. Lasa M, Brook M, Saklatvala J, Clark AR 2001 Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol 21:771-780
65. Garcia-Fernandez LF, Iniguez MA, Eguchi N, Fresno M, Urade Y, Munoz A 2000 Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells. J Neurochem 75:460-470
66. Sorrells SF, Sapolsky RM 2006 An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 21:259-272
67. Gorman AL, Dunn AJ 1993 β-Adrenergic receptors are involved in stress-related behavioral changes. Pharmacol Biochem Behav 45:1-7
68. Kabbaj M, Piazza PV, Simon H, Le Moal M, Maccari S 1995 Opposite Effects on hippocampal corticosteroid receptors induced by stimulation of β and α 1 noradrenergic receptors. Neuroscience 66:539-545
69. Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA 2000 Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 293:417-425
70. Takadera T, Yumoto H, Tozuka Y, Ohyashiki T 2002 Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci Lett 317:61-64
71. Akaike A, Kaneko S, Tamura Y, Nakata N, Shiomi H, Ushikubi F, Narumiya S 1994 Prostaglandin E2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 663:237-243
72. Thery C, Dobbertin A, Mallat M 1994 Downregulation of in vitro neurotoxicity of brain macrophages by prostaglandin E2 and a β-adrenergic agonist. Glia 11:383-386
73. Kim EJ, Kwon KJ, Park JY, Lee SH, Moon CH, Baik EJ 2002 Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J Neurosci Res 70:97-107
74. Pepicelli O, Fedele E, Bonanno G, Raiteri M, Ajmone-Cat MA, Greco A, Levi G, Minghetti L 2002 In vivo activation of N-methyl- D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem 81:1028-1034
75. Aoun P, Watson DG, Simpkins JW 2003 Neuroprotective effects of PPARγ agonists against oxidative insults in HT-22 cells. Eur J Pharmacol 472:65-71
76. Zhao X, Ou Z, Grotta JC, Waxham N, Aronowski J 2006 Peroxisome proliferator-activated receptor-γ (PPARγ) activation protects neurons from NMDA excitotoxicity. Brain Res 1073-1074:460-469
77. Daynes RA, Jones DC 2002 Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2:748-759
78. Shao D, Rangwala SM, Bailey ST, Krakow SL, Reginato MJ, Lazar MA 1998 Interdomain communication regulating ligand binding by PPAR-γ. Nature 396:377-380
79. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, Caro JF, Flier JS 1997 Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99:2416-2422
80. Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J, Wahli W 1994 Regulation of the peroxisome proliferator-activated receptor α gene by glucocorticoids. J Biol Chem 269:24527-24530
81. Klotz L, Sastre M, Kreutz A, Gavrilyuk V, Klockgether T, Feinstein DL, Heneka MT 2003 Noradrenaline induces expression of peroxisome proliferator activated receptor γ (PPARγ) in murine primary astrocytes and neurons. J Neurochem 86:907-916
82. Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, Serena J, Vivancos J, Nombela F, Lorenzo P, Lizasoain I, Moro MA 2007 Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARγ target gene involved in neuroprotection. J Cereb Blood Flow Metab 27:1327-1338